Mariana X. Navarro

Mariana X. Navarro

Auto-generated profile, based on publicly available information

Mariana X. Navarro

Department of Chemistry, University of Southern California, Los Angeles, CA 90089

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
PLPaul M. Levine
Paul M. Levine
AGAna Galesic
Ana Galesic
ABAaron T. Balana
Aaron T. Balana
AMAnne-Laure Mahul-Mellier
Anne-Laure Mahul-Mellier
MNMariana X. Navarro
Mariana X. Navarro
MPMatthew Pratt
Matthew Pratt
Significance: Preventing the aggregation of toxic proteins in neurodegenerative diseases is both an important biological function and a potential therapeutic strategy. Here, we examine the consequences of O-GlcNAcylation on the aggregation and toxicity of α-synuclein, the aggregating protein in Parkinson’s disease. α-Synuclein is modified by O-GlcNAc at at least nine different positions in vivo, but the consequences of most of these modifications are unknown. Here, we use synthetic protein chemistry to prepare six different O-GlcNAcylated forms of α-synuclein and show that they have largely inhibitory, but site-specific, effects on the aggregation and cellular toxicity of this protein. These results suggest that O-GlcNAc may be a cellular strategy to prevent protein aggregation, which could potentially be exploited for treatment.